These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20934258)

  • 21. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung.
    Schobert M; Jahn D
    Int J Med Microbiol; 2010 Dec; 300(8):549-56. PubMed ID: 20951638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Int J Med Microbiol; 2010 Dec; 300(8):557-62. PubMed ID: 20943439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrinsic and environmental mutagenesis drive diversification and persistence of Pseudomonas aeruginosa in chronic lung infections.
    Rodríguez-Rojas A; Oliver A; Blázquez J
    J Infect Dis; 2012 Jan; 205(1):121-7. PubMed ID: 22080096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    O'May CY; Reid DW; Kirov SM
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):373-80. PubMed ID: 17052266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary host defense: defects that lead to chronic inflammation of the airway.
    Hornick DB
    Clin Chest Med; 1988 Dec; 9(4):669-78. PubMed ID: 3148383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities?
    Kirisits MJ; Parsek MR
    Cell Microbiol; 2006 Dec; 8(12):1841-9. PubMed ID: 17026480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biosignificance of bacterial cyanogenesis in the CF lung.
    Anderson RD; Roddam LF; Bettiol S; Sanderson K; Reid DW
    J Cyst Fibros; 2010 May; 9(3):158-64. PubMed ID: 20156704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway.
    Williams HD; Davies JC
    Thorax; 2012 May; 67(5):465-7. PubMed ID: 22382597
    [No Abstract]   [Full Text] [Related]  

  • 32. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia.
    Tomlin KL; Coll OP; Ceri H
    Can J Microbiol; 2001 Oct; 47(10):949-54. PubMed ID: 11718549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis.
    Smith DJ; Lamont IL; Anderson GJ; Reid DW
    Eur Respir J; 2013 Dec; 42(6):1723-36. PubMed ID: 23143541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.
    Jensen PØ; Kolpen M; Kragh KN; Kühl M
    APMIS; 2017 Apr; 125(4):276-288. PubMed ID: 28407427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model.
    Rodríguez-Sevilla G; García-Coca M; Romera-García D; Aguilera-Correa JJ; Mahíllo-Fernández I; Esteban J; Pérez-Jorge C
    Int J Med Microbiol; 2018 Apr; 308(3):413-423. PubMed ID: 29555180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbial ecology and adaptation in cystic fibrosis airways.
    Yang L; Jelsbak L; Molin S
    Environ Microbiol; 2011 Jul; 13(7):1682-9. PubMed ID: 21429065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent infections and immunity in cystic fibrosis.
    Yu H; Head NE
    Front Biosci; 2002 Feb; 7():d442-57. PubMed ID: 11815305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites.
    Bielecki P; Komor U; Bielecka A; Müsken M; Puchałka J; Pletz MW; Ballmann M; Martins dos Santos VA; Weiss S; Häussler S
    Environ Microbiol; 2013 Feb; 15(2):570-87. PubMed ID: 23145907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.
    Høiby N; Krogh Johansen H; Moser C; Song Z; Ciofu O; Kharazmi A
    Microbes Infect; 2001 Jan; 3(1):23-35. PubMed ID: 11226851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.